Liver biopsy is the gold standard for diagnosing NAFLD as well as confirming the presence of NASH. However, liver biopsy is an invasive procedure and therefore is not routinely favored by ...

In this study, 58.8% patients were diagnosed with NASH at the first liver biopsy. The second biopsy after RYGB showed resolution of NASH in all patients. In a study of 16 patients, Csendes et al ...

With no treatment currently approved to treat NASH, the market opportunity is substantially large. Importantly, the drug’s label does not include a requirement for liver biopsy for diagnosis.

or NASH, and moderate to advanced liver fibrosis, according to a statement Thursday from West Conshohocken, Pennsylvania-based Madrigal. Patients won’t need an invasive liver biopsy to get the ...

As mentioned earlier, finding out whether a patient has NASH requires an in-hospital liver biopsy. An NAFLD diagnosis also offers no insights into the etiology of the patient’s disease ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. It encompasses a wide spectrum of liver lesions, from pure steatosis to end-stage liver disease with ...